Colgate-Palmolive (NYSE: CL) reported Q4 EPS of $0.79, in-line with the analyst estimate of $0.79. Revenue for the quarter came in at $4.4 billion versus the consensus estimate of $4.43 billion.

Full Year 2022 Guidance

Based on current spot rates:

• The Company expects net sales growth to be 1% to 4% including a low-single-digit negative impact from foreign exchange.
• The Company expects organic sales growth to be within its long-term targeted range of 3% to 5%.
• On a GAAP basis, the Company expects gross profit margin expansion, increased advertising investment and double-digit earnings-per-share growth.
• On a non-GAAP (Base Business) basis, the Company expects gross profit margin expansion, increased advertising investment and low to mid-single-digit earnings-per-share growth.

For earnings history and earnings-related data on Colgate-Palmolive (CL) click here.